Ticker
INOCompany Name
INOVIO PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -94.79M | -51987.6% | $ 182.34K |
3/31/2025 | $ -102.19M | -36097.13% | $ 283.1K |
12/31/2024 | $ -104.08M | -47795.03% | $ 217.76K |
9/30/2024 | $ -110.69M | -54415.61% | $ 203.41K |
6/30/2024 | $ -112.36M | -18983.53% | $ 591.86K |
3/31/2024 | $ -116.46M | -16241.28% | $ 717.07K |
12/31/2023 | $ -124.37M | -14947.6% | $ 832.01K |
9/30/2023 | $ -134.43M | -15740.71% | $ 854.03K |
6/30/2023 | $ -172.78M | -1796.15% | $ 9.62M |
3/31/2023 | $ -191M | -1876.55% | $ 10.18M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / Revenues
(=) OCF %
OCF % for INOVIO PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -140.5M ] / Revenues [ $ 2.11M ]
(=) OCF % [ -6658.36% ]
Minimum
Sep 30, 2024
Maximum
Jun 30, 2023
Average
Median
filtered constituents | 3.25K |
---|---|
min | -57.27% |
max | 78.12% |
average | 14.35% |
median | 12.67% |
std | 21.14% |